CNSX:LHS - Liberty Health Sciences Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.99 -0.02 (-1.98 %)
(As of 12/14/2018 11:54 AM ET)
Previous Close$1.01
Today's Range$0.92 - $1.04
52-Week Range$0.63 - $2.30
Volume726,783 shs
Average Volume346,771 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Receive LHS News and Ratings via Email

Sign-up to receive the latest news and ratings for LHS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange CNSX
Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolCNSX:LHS
Previous Symbol
CUSIPN/A
Phone+1-647-7254185

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A
Market Cap$0.00
OptionableNot Optionable

Liberty Health Sciences (CNSX:LHS) Frequently Asked Questions

What is Liberty Health Sciences' stock symbol?

Liberty Health Sciences trades on the CNSX under the ticker symbol "LHS."

What price target have analysts set for LHS?

1 analysts have issued twelve-month target prices for Liberty Health Sciences' stock. Their predictions range from $2.00 to $2.00. On average, they expect Liberty Health Sciences' share price to reach $2.00 in the next year. This suggests a possible upside of 102.0% from the stock's current price. View Analyst Price Targets for Liberty Health Sciences.

What is the consensus analysts' recommendation for Liberty Health Sciences?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Liberty Health Sciences in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Liberty Health Sciences.

Has Liberty Health Sciences been receiving favorable news coverage?

Media headlines about LHS stock have trended somewhat positive on Friday, InfoTrie reports. InfoTrie identifies positive and negative news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Liberty Health Sciences earned a news impact score of 1.8 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 3.0 out of 10, meaning that recent news coverage is unlikely to have an impact on the company's share price in the near future.

How do I buy shares of Liberty Health Sciences?

Shares of LHS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Liberty Health Sciences' stock price today?

One share of LHS stock can currently be purchased for approximately $0.99.

What is Liberty Health Sciences' official website?

The official website for Liberty Health Sciences is https://libertyhealthsciences.com/.

How can I contact Liberty Health Sciences?

Liberty Health Sciences' mailing address is 35 McCaul St 2nd Floor, TORONTO, ON M5T 1V7, Canada. The company can be reached via phone at +1-647-7254185.


MarketBeat Community Rating for Liberty Health Sciences (CNSX LHS)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  22 (Vote Outperform)
Underperform Votes:  22 (Vote Underperform)
Total Votes:  44
MarketBeat's community ratings are surveys of what our community members think about Liberty Health Sciences and other stocks. Vote "Outperform" if you believe LHS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LHS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/14/2018 by MarketBeat.com Staff

Featured Article: Swap

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel